Artelo Biosciences, Inc.’s Post

Weight is only part of the story. In cancer anorexia-cachexia syndrome (#CACS), patients often lose critical lean body mass—the muscle that supports strength, mobility, and daily activity. In the interim Phase 2 CAReS trial, patients treated with #ART27_13 gained an average of +4% lean body mass after one month, while those on placebo gained 0%. Preserving and rebuilding lean muscle means more than numbers on a scale—it represents hope for better function, independence, and quality of life for patients facing this devastating condition. Learn more about the trial results: https://lnkd.in/g-NsmFA6